GARUX | NABIX | GARUX / NABIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 12 years | - |
Gain YTD | 7.234 | 2.816 | 257% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 1000000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.39B | 92.9M | 4,726% |
Annual Yield % from dividends | 2.63 | 0.92 | 288% |
Returns for 1 year | 11.59 | 3.69 | 314% |
Returns for 3 years | 2.99 | 12.80 | 23% |
Returns for 5 years | 11.02 | 19.14 | 58% |
Returns for 10 years | N/A | 19.94 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 14.50 | 0.21 | +1.47% |
ProShares UltraShort Nasdaq Biotech | |||
GFEB | 36.43 | 0.03 | +0.10% |
FT Cboe Vest U.S. Eq Mod Buffr ETF - Feb | |||
MART | 32.71 | -0.02 | -0.05% |
AllianzIM U.S. Large Cp Buffer10 Mar ETF | |||
SBIO | 38.79 | -0.13 | -0.33% |
ALPS Medical Breakthroughs ETF | |||
FXR | 74.96 | -0.73 | -0.96% |
First Trust Indtls/PrdcrDurbAlphaDEX®ETF |